Skip to main content
Log in

Erlotinib/gemcitabine

Lung and skin disorders: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Boeck S, Hausmann A, Reibke R, Schulz C, Heinemann V.Severe interstitial lung disease during treatment with gemcitabine and erlotinib for metastatic pancreatic cancer - a case report. Onkologie 30 (Suppl. 3): 221, Oct 2007 - Germany

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erlotinib/gemcitabine. React. Wkly. 1182, 17 (2007). https://doi.org/10.2165/00128415-200711820-00051

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711820-00051

Keywords

Navigation